Quantitative CT analysis in ILD and use of artificial intelligence on imaging of ILD

Advances in computer technology over the past decade, particularly in the field of medical image analysis, have permitted the identification, characterisation and quantitation of abnormalities that can be used to diagnose disease or determine disease severity. On CT imaging performed in patients with ILD, deep-learning computer algorithms now demonstrate comparable performance with trained observers in the identification of a UIP pattern, which is associated with a poor prognosis in several fibrosing ILDs. Computer tools that quantify individual voxel-level CT features have also come of age and can predict mortality with greater power than visual CT analysis scores. As these tools become more established, they have the potential to improve the sensitivity with which minor degrees of disease progression are identified. Currently, PFTs are the gold standard measure used to assess clinical deterioration. However, the variation associated with pulmonary function measurements may mask the presence of small but genuine functional decline, which in the future could be confirmed by computer tools. The current chapter will describe the latest advances in quantitative CT analysis and deep learning as related to ILDs and suggest potential future directions for this rapidly advancing field

Lancet Respir Med

The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4-9% of smokers and 2-7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.R01 CA092824/CA/NCI NIH HHSUnited States/R01 HL130974/HL/NHLBI NIH HHSUnited States/R01 CA074386/CA/NCI NIH HHSUnited States/R01 HL111024/HL/NHLBI NIH HHSUnited States/R01 HL135142/HL/NHLBI NIH HHSUnited States/R21 CA116271/CA/NCI NIH HHSUnited States/R01 ES009860/ES/NIEHS NIH HHSUnited States/R01 OH002421/OH/NIOSH CDC HHSUnited States/R01 CA203636/CA/NCI NIH HHSUnited States/U01 CA209414/CA/NCI NIH HHSUnited States/2021-01-01T00:00:00Z32649920PMC7970441992

深層学習における訓練データの性質がCOVID-19画像診断性能に与える影響に関する研究

Tohoku University博士（医工学）thesi

Lung Pattern Analysis using Artificial Intelligence for the Diagnosis Support of Interstitial Lung Diseases

Interstitial lung diseases (ILDs) is a group of more than 200 chronic lung disorders characterized by inflammation and scarring of the lung tissue that leads to respiratory failure. Although ILD is a heterogeneous group of histologically distinct diseases, most of them exhibit similar clinical presentations and their diagnosis often presents a diagnostic dilemma. Early diagnosis is crucial for making treatment decisions, while misdiagnosis may lead to life-threatening complications. If a final diagnosis cannot be reached with the high resolution computed tomography scan, additional invasive procedures are required (e.g. bronchoalveolar lavage, surgical biopsy). The aim of this PhD thesis was to investigate the components of a computational system that will assist radiologists with the diagnosis of ILDs, while avoiding the dangerous, expensive and time-consuming invasive biopsies. The appropriate interpretation of the available radiological data combined with clinical/biochemical information can provide a reliable diagnosis, able to improve the diagnostic accuracy of the radiologists. In this thesis, we introduce two convolutional neural networks particularly designed for ILDs and a training scheme that employs knowledge transfer from the similar domain of general texture classification for performance enhancement. Moreover, we investigate the clinical relevance of breathing information for disease classification. The breathing information is quantified as a deformation field between inhale-exhale lung images using a novel 3D convolutional neural network for medical image registration. Finally, we design and evaluate the final end-to-end computational system for ILD classification using lung anatomy segmentation algorithms from the literature and the proposed ILD quantification neural networks. Deep learning approaches have been mostly investigated for all the aforementioned steps, while the results demonstrated their potential in analyzing lung images

Deep learning in medical imaging and radiation therapy

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/146980/1/mp13264_am.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/146980/2/mp13264.pd

Sparse feature learning for image analysis in segmentation, classification, and disease diagnosis.

The success of machine learning algorithms generally depends on intermediate data representation, called features that disentangle the hidden factors of variation in data. Moreover, machine learning models are required to be generalized, in order to reduce the specificity or bias toward the training dataset. Unsupervised feature learning is useful in taking advantage of large amount of unlabeled data, which is available to capture these variations. However, learned features are required to capture variational patterns in data space. In this dissertation, unsupervised feature learning with sparsity is investigated for sparse and local feature extraction with application to lung segmentation, interpretable deep models, and Alzheimer\u27s disease classification. Nonnegative Matrix Factorization, Autoencoder and 3D Convolutional Autoencoder are used as architectures or models for unsupervised feature learning. They are investigated along with nonnegativity, sparsity and part-based representation constraints for generalized and transferable feature extraction

Deep Learning in Medical Image Analysis

The accelerating power of deep learning in diagnosing diseases will empower physicians and speed up decision making in clinical environments. Applications of modern medical instruments and digitalization of medical care have generated enormous amounts of medical images in recent years. In this big data arena, new deep learning methods and computational models for efficient data processing, analysis, and modeling of the generated data are crucially important for clinical applications and understanding the underlying biological process. This book presents and highlights novel algorithms, architectures, techniques, and applications of deep learning for medical image analysis

Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases

Cardiothoracic and pulmonary diseases are a significant cause of mortality and morbidity worldwide. The COVID-19 pandemic has highlighted the lack of access to clinical care, the overburdened medical system, and the potential of artificial intelligence (AI) in improving medicine. There are a variety of diseases affecting the cardiopulmonary system including lung cancers, heart disease, tuberculosis (TB), etc., in addition to COVID-19-related diseases. Screening, diagnosis, and management of cardiopulmonary diseases has become difficult owing to the limited availability of diagnostic tools and experts, particularly in resource-limited regions. Early screening, accurate diagnosis and staging of these diseases could play a crucial role in treatment and care, and potentially aid in reducing mortality. Radiographic imaging methods such as computed tomography (CT), chest X-rays (CXRs), and echo ultrasound (US) are widely used in screening and diagnosis. Research on using image-based AI and machine learning (ML) methods can help in rapid assessment, serve as surrogates for expert assessment, and reduce variability in human performance. In this Special Issue, “Artificial Intelligence in Image-Based Screening, Diagnostics, and Clinical Care of Cardiopulmonary Diseases”, we have highlighted exemplary primary research studies and literature reviews focusing on novel AI/ML methods and their application in image-based screening, diagnosis, and clinical management of cardiopulmonary diseases. We hope that these articles will help establish the advancements in AI